Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotype.
Bardet
V
V
Costa
L D
LD
Elie
C
C
Malinge
S
S
Demur
C
C
Tamburini
J
J
Lefebvre
P C
PC
Witz
F
F
Lioure
B
B
Jourdan
E
E
Pigneux
A
A
Ifrah
N
N
Attal
M
M
Dreyfus
F
F
Mayeux
P
P
Lacombe
C
C
Bennaceur-Griscelli
A
A
Bernard
O A
OA
Bouscary
D
D
Récher
C
C
D000208:Acute Disease; D006801:Humans; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery*; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics*; D000090243:Nucleophosmin; D016133:Polymerase Chain Reaction
C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D000090243:Nucleophosmin